Aperio Group, LLC - CADENCE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 100 filers reported holding CADENCE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Aperio Group, LLC ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$109,000
+43.4%
12,0920.0%0.00%
+100.0%
Q3 2013$76,000
-9.5%
12,092
-2.1%
0.00%
-50.0%
Q2 2013$84,000–12,351–0.00%–
 Download
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q4 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders